Full text is available at the source.
Glucagon-Like Peptide-1 Receptor Agonists in the Peri-Operative Period
Use of Glucagon-Like Peptide-1 Receptor Agonists Around the Time of Surgery
AI simplified
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may be associated with an increased risk of pulmonary aspiration due to drug-induced gastroparesis.
- GLP-1 RAs are becoming significant in treating Type 2 Diabetes Mellitus and obesity.
- Concerns have been raised regarding the potential for pulmonary aspiration in patients using these medications.
- The link between GLP-1 RAs and pulmonary aspiration is not definitively established.
- Current evidence suggests a need for cautious management of patients on GLP-1 RAs.
AI simplified